TWD 13.05
(0.77%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 261.7 Million | 167.59 Million | 199.31 Million | 101.62 Million | -93.77 Million | -214.31 Million |
Net Income | 95.1 Million | 106.99 Million | 369.5 Million | -367.98 Million | -166.36 Million | 240.73 Million |
Depreciation & Amortization | 30.48 Million | 28.97 Million | 26.57 Million | 70.31 Million | 82.07 Million | 83.89 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 98.41 Million | 29.93 Million | 142.15 Million | 21.98 Million | -41.38 Million | -2.72 Million |
Other non-cash items | 37.71 Million | 1.7 Million | -338.91 Million | 377.31 Million | 31.9 Million | -536.21 Million |
Investing Cash Flow | -293.03 Million | -472.24 Million | 2.94 Billion | -29.14 Million | 315.63 Million | 784.71 Million |
Investments in PPE | -8.19 Million | -4.61 Million | -22.37 Million | -15.47 Million | -9.23 Million | -130.06 Million |
Acquisitions | 74.84 Million | - | -15.93 Million | -3.45 Million | 336 Thousand | 2.35 Million |
Investment purchases | -1.9 Billion | -1.03 Billion | -1.29 Billion | -8.8 Million | -5.01 Million | - |
Sales/Maturities of investments | 1.57 Billion | 574.91 Million | 113.05 Million | - | 289.1 Million | 162.36 Million |
Other Investing Activities | -27.12 Million | -4.72 Million | 4.16 Billion | -1.4 Million | 40.44 Million | 912.42 Million |
Financing Cash Flow | -51.96 Million | 313.99 Million | -3.17 Billion | 182.75 Million | -268.62 Million | -1.01 Billion |
Debt repayment | -66.27 Million | -163 Million | -3.1 Billion | -800 Million | -290 Million | -730 Million |
Dividends payments | -102.41 Million | -95.96 Million | -92.67 Million | - | -222.41 Million | -222.41 Million |
Common Stock Repurchased | - | -4.9 Million | - | - | -3.44 Million | - |
Common Stock Issuance | - | - | - | 4.12 Million | 3.44 Million | - |
Other Financing Activities | 116.72 Million | 577.86 Million | 25.73 Million | 978.62 Million | 243.78 Million | -59.44 Million |
Accounts receivables | -10.84 Million | 45.73 Million | 14.57 Million | 1.56 Million | -3.77 Million | 12.53 Million |
Accounts payables | -1.54 Million | -639 Thousand | 4.48 Million | -18.03 Million | -10.44 Million | -76.44 Million |
Inventory | 17.78 Million | 24 Thousand | 30.75 Million | 30 Million | 22.07 Million | 78.99 Million |
Other working capital | 93.01 Million | -15.18 Million | 92.33 Million | 8.45 Million | -49.23 Million | -81.72 Million |
Cash at beginning of period | 311.14 Million | 301.62 Million | 336.87 Million | 81.87 Million | 128.57 Million | 569.06 Million |
Cash at end of period | 233.14 Million | 311.14 Million | 301.62 Million | 336.87 Million | 81.87 Million | 128.57 Million |
Capital Expenditure | -8.19 Million | -4.61 Million | -22.37 Million | -15.47 Million | -9.23 Million | -130.06 Million |
Effect of forex changes on cash | 5.29 Million | 176 Thousand | -131 Thousand | -239 Thousand | 76 Thousand | 964 Thousand |
Net cash flow / Change in cash | -77.99 Million | 9.52 Million | -35.25 Million | 254.99 Million | -46.69 Million | -440.49 Million |
Free Cash Flow | 253.51 Million | 162.98 Million | 176.93 Million | 86.14 Million | -103 Million | -344.38 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 51.55 Million | 43.32 Million | 95.1 Million | -23.12 Million | 132.97 Million | 21.94 Million |
Depreciation & Amortization | 7 Million | 7.31 Million | 30.48 Million | 8.01 Million | 7.77 Million | 7.27 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 5.85 Million | -94.91 Million | 98.41 Million | 70.69 Million | -63.14 Million | -16.91 Million |
Other non-cash items | 15.52 Million | -3.01 Million | 37.71 Million | 19.26 Million | 32.25 Million | -28.52 Million |
Investing Cash Flow | -70.54 Million | -212.4 Million | -293.03 Million | -15.55 Million | -174.46 Million | -18.04 Million |
Investments in PPE | -325 Thousand | -4.28 Million | -8.19 Million | -1.54 Million | -705 Thousand | -5.17 Million |
Acquisitions | - | - | 74.84 Million | 73.7 Million | -1000.00 | -3.42 Million |
Investment purchases | -2.72 Billion | -258.51 Million | -1.9 Billion | 1.37 Billion | -1.76 Billion | -882.75 Million |
Sales/Maturities of investments | 2.65 Billion | 3.8 Million | 1.57 Billion | -1.41 Billion | 1.55 Billion | 861.65 Million |
Other Investing Activities | -1.98 Million | 46.58 Million | -27.12 Million | -46.21 Million | 34.26 Million | 11.65 Million |
Financing Cash Flow | 33.09 Million | 117.14 Million | -51.96 Million | 31.83 Million | -70.45 Million | 8.95 Million |
Debt repayment | -51.51 Million | -124.04 Million | -66.27 Million | -51.07 Million | -15.5 Million | -7.31 Million |
Dividends payments | - | -3000.00 | -102.41 Million | -6.73 Million | -92.67 Million | -3 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -14.75 Million | -3.24 Million | 116.72 Million | 89.64 Million | 37.72 Million | 19.26 Million |
Accounts receivables | 3.56 Million | -14.03 Million | -10.84 Million | -24.04 Million | -35.08 Million | -4.55 Million |
Accounts payables | -1.76 Million | -26 Thousand | -1.54 Million | 1.35 Million | -1.73 Million | 906 Thousand |
Inventory | - | - | 17.78 Million | - | -21.37 Million | -21 Thousand |
Other working capital | 4.05 Million | -80.87 Million | 93.01 Million | 93.38 Million | -4.94 Million | -13.24 Million |
Cash at beginning of period | 153.47 Million | 233.14 Million | 311.14 Million | 134.17 Million | 268.8 Million | 296.99 Million |
Cash at end of period | 208.71 Million | 153.47 Million | 233.14 Million | 233.14 Million | 134.17 Million | 268.8 Million |
Capital Expenditure | -325 Thousand | -4.28 Million | -8.19 Million | -1.54 Million | -705 Thousand | -5.17 Million |
Effect of forex changes on cash | 24.97 Million | 66.93 Million | 5.29 Million | 7.84 Million | 419 Thousand | -2.88 Million |
Net cash flow / Change in cash | 55.24 Million | -79.67 Million | -77.99 Million | 98.97 Million | -134.63 Million | -28.19 Million |
Free Cash Flow | 67.39 Million | -55.62 Million | 253.51 Million | 73.31 Million | 109.16 Million | -21.39 Million |
APTECHT
603901
DOSE
6124
AYGAZ
1472